As the generic industry seeks clarity on so-called "skinny" drug labels, the United States’ top lawyer is calling on the Supreme Court to take up the long-running feud between Teva and GSK.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,